377 related articles for article (PubMed ID: 35185870)
21. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
Kap YS; van Driel N; Arends R; Rouwendal G; Verolin M; Blezer E; Lycke N; 't Hart BA
Clin Exp Immunol; 2015 Apr; 180(1):28-39. PubMed ID: 25393803
[TBL] [Abstract][Full Text] [Related]
22. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
[TBL] [Abstract][Full Text] [Related]
23. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice.
Litzenburger T; Fässler R; Bauer J; Lassmann H; Linington C; Wekerle H; Iglesias A
J Exp Med; 1998 Jul; 188(1):169-80. PubMed ID: 9653093
[TBL] [Abstract][Full Text] [Related]
24. Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background.
Yeola AP; Ignatius Arokia Doss PM; Baillargeon J; Akbar I; Mailhot B; Balood M; Talbot S; Anderson AC; Lacroix S; Rangachari M
Front Immunol; 2019; 10():3115. PubMed ID: 32010149
[TBL] [Abstract][Full Text] [Related]
25. Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
Delarasse C; Smith P; Baker D; Amor S
Immunology; 2013 Dec; 140(4):456-64. PubMed ID: 23876060
[TBL] [Abstract][Full Text] [Related]
26. Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model.
Khare P; Challa DK; Devanaboyina SC; Velmurugan R; Hughes S; Greenberg BM; Ober RJ; Ward ES
J Autoimmun; 2018 Jan; 86():104-115. PubMed ID: 28964723
[TBL] [Abstract][Full Text] [Related]
27. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
Weber MS; Prod'homme T; Patarroyo JC; Molnarfi N; Karnezis T; Lehmann-Horn K; Danilenko DM; Eastham-Anderson J; Slavin AJ; Linington C; Bernard CC; Martin F; Zamvil SS
Ann Neurol; 2010 Sep; 68(3):369-83. PubMed ID: 20641064
[TBL] [Abstract][Full Text] [Related]
28. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice.
Ben-Nun A; Kerlero de Rosbo N; Kaushansky N; Eisenstein M; Cohen L; Kaye JF; Mendel I
Eur J Immunol; 2006 Feb; 36(2):478-93. PubMed ID: 16453383
[TBL] [Abstract][Full Text] [Related]
29. ESC-derived thymic epithelial cells expressing MOG prevents EAE by central and peripheral tolerance mechanisms.
Su M; Lin Y; Cui C; Tian X; Lu X; He Z; Lai L
Cell Immunol; 2017 Dec; 322():84-91. PubMed ID: 29074250
[TBL] [Abstract][Full Text] [Related]
30. Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG.
Sinha S; Subramanian S; Emerson-Webber A; Lindner M; Burrows GG; Grafe M; Linington C; Vandenbark AA; Bernard CC; Offner H
J Neuroimmune Pharmacol; 2010 Jun; 5(2):231-9. PubMed ID: 19789980
[TBL] [Abstract][Full Text] [Related]
31. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
[TBL] [Abstract][Full Text] [Related]
32. Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis.
Tsunoda I; Libbey JE; Kuang LQ; Terry EJ; Fujinami RS
Am J Pathol; 2005 Dec; 167(6):1631-46. PubMed ID: 16314476
[TBL] [Abstract][Full Text] [Related]
33. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains.
Tsunoda I; Kuang LQ; Theil DJ; Fujinami RS
Brain Pathol; 2000 Jul; 10(3):402-18. PubMed ID: 10885659
[TBL] [Abstract][Full Text] [Related]
34. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
Pol S; Schweser F; Bertolino N; Preda M; Sveinsson M; Sudyn M; Babek N; Zivadinov R
Exp Neurol; 2019 Apr; 314():82-90. PubMed ID: 30684521
[TBL] [Abstract][Full Text] [Related]
35. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
36. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.
Adelmann M; Wood J; Benzel I; Fiori P; Lassmann H; Matthieu JM; Gardinier MV; Dornmair K; Linington C
J Neuroimmunol; 1995 Dec; 63(1):17-27. PubMed ID: 8557821
[TBL] [Abstract][Full Text] [Related]
37. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
38. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
[TBL] [Abstract][Full Text] [Related]
39. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
[TBL] [Abstract][Full Text] [Related]
40. Passive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells.
Mannara F; Valente T; Saura J; Graus F; Saiz A; Moreno B
PLoS One; 2012; 7(12):e52361. PubMed ID: 23300649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
